COVID-19 Testing and Diagnosis in Children Under Six Years of Age: A Systematic Review

Date
2024
Authors
Ure, Kirsty
Supervisor
Foster, Mandie
Item type
Thesis
Degree name
Master of Health Practice
Journal Title
Journal ISSN
Volume Title
Publisher
Auckland University of Technology
Abstract

Introduction: Severe acute respiratory syndrome was first detected in 2003 and escalated in 2019 with COVID-19 causing a worldwide pandemic. This new virus presented challenges in diagnosis, especially in those under 6 years of age. While often classified as a mild disease in children, COVID-19 still presents significant health risks in the young, especially for children under 1 year of age and those with pre-existing comorbidities. Because of this, clinical guidelines and protocols addressing COVID-19 testing in preschool- aged children became necessary to direct evidence-based practice.

Aim: The aim of this systematic review was to explore COVID-19 testing and diagnosis in children under 6 years of age from international peer-reviewed published manuscripts to facilitate a wider and more thorough understanding of this practice from a diverse sample of parents, children, and health care providers to inform and direct practice within Aotearoa/New Zealand.

Methods: A systematic review was undertaken based on guidelines by Siddaway et al. (2019). Extant empirical research published in peer-reviewed journals from 2020–2024 on COVID-19 testing in children under 6 years of age was identified from Scopus, CINAHL, MEDLINE via PubMed, and PsycInfo via Ovid databases. Data were analysed using deductive thematic analysis.

Findings: Fourteen studies involving over 5,000 participants were included. Deductive content analysis identified seven key areas: 1. Symptomology, 2. Diagnostic tests, 4. Efficacy and acceptability of testing, 4. Viral loads, 5. Vulnerability/Risk factors, 6. Health outcomes, and 7. Recommendations.

Conclusion: While common symptoms such as fever and cough are prevalent in children under 6 years of age infected with COVID-19, symptomology alone is not a foolproof diagnostic tool. Additional diagnostic testing, such as nasopharyngeal swabs and polymerase chain reaction testing, is complementary to diagnosis. However, an understanding of the risk factors for contracting COVID-19, as well as the vulnerability and health outcomes of children with COVID-19, is important to consider.

Implications for practice: Common symptomology for children under 6 years of age includes fever and cough; however, these symptoms are also common for other viruses. A history of exposure to COVID-19 is the most frequent positive predictive factor for infection. An assessment of the child before any decisions on diagnostic testing is useful.

Description
Keywords
Source
DOI
Publisher's version
Rights statement